Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo
Abstract
Cholangiocarcinoma is the most common biliary duct malignancy and the second most common primary liver cancer, accounting for 10‑20% of hepatic malignancies. With high mortality and poor prognosis, the 5‑year survival rate of cholangiocarcinoma is only 10%. A previous study demonstrated a significant association between aspirin use and a decreased risk of cholangiocarcinoma. However, the effect of aspirin on cholangiocarcinoma remains unknown....
Paper Details
Title
Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo
Published Date
Dec 30, 2020
Volume
58
Issue
2
Pages
199 - 210
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History